The American College of Cardiology announced the late-breaking science lineup for its Scientific Session to be held March ...

For people with atrial fibrillation (Afib), investigational abelacimab proved to be a potent dual factor XI/XIa inhibitor with much lower safety risks compared with a direct oral anticoagulant (DOAC), ...

Bankers are betting the Trump administration heralds a new wave of megamergers that wasn’t feasible under former president’s ...

IMMvention retained rights to use its technology to potentially pursue other targets, such as Parkinson’s or Alzheimer’s ...